Yooma Wellness Inc. (YOOM.CN)
| Previous Close | 0.0050 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0050 x N/A |
| Day's Range | 0.0050 - 0.0050 |
| 52 Week Range | 0.0050 - 0.0050 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 504,300 |
| Beta (5Y Monthly) | 2.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
YOOMA WELLNESS INC. ANNOUNCES SALE OF VITALITY CBD
Toronto, Ontario, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (CSE: YOOM, AQSE: YOOM) ("Yooma" or the "Company") today announced that its wholly-owned subsidiary Yooma Europe Limited (“Yooma Europe”) has completed the sale of Birmingham-based Vitality CBD Limited (“Vitality”), a UK-focused CBD company, for a total consideration of US$2.0 million (the “Disposal”) to Psilobrain Therapeutics Inc. (“Psilobrain”). Psilobrain is a private Canadian biotech company that uses the latest in psy
- GlobeNewswire
YOOMA WELLNESS INC. ISSUED CEASE TRADE ORDER FOR DELAY IN ANNUAL FILINGS
Toronto, Ontario, May 08, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (CSE: YOOM, AQSE: YOOM) ("Yooma" or the "Company") today announced that it has been issued a cease trade order (“CTO”) by the Ontario Securities Commission (“OSC”) in connection with its failure to file its audited annual financial statements for the financial year ended December 31, 2022, together with the corresponding management discussion and analysis and CEO/CFO certifications, (collectively, the “Annual Filings”) by the
